Biomarin Pharmaceutical (BMRN) Property, Plant & Equipment (Net) (2009 - 2026)

Biomarin Pharmaceutical (BMRN) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Oculis Holding AG	67,132.22 Bn	67,131.94 Bn	-	642,333.36
2	Nanobiotix	1,910.87 Bn	1,910.81 Bn	-	5.32 Mn
3	Akari Therapeutics	989.71 Bn	989.71 Bn	-	-
4	BeOne Medicines	471.60 Bn	466.80 Bn	1.35 Bn	1.64 Bn
5	Vertex Pharmaceuticals	121.71 Bn	114.46 Bn	2.59 Bn	1.61 Bn
6	Regeneron Pharmaceuticals	69.83 Bn	61.07 Bn	3.31 Bn	5.27 Bn
7	Belite Bio	62.74 Bn	62.74 Bn	-	-
8	Argenx Se	55.83 Bn	50.65 Bn	1.41 Bn	1.96 Bn
9	Alnylam Pharmaceuticals	37.33 Bn	34.32 Bn	959.66 Mn	518.26 Mn
10	Biomarin Pharmaceutical	11.67 Bn	9.45 Bn	571.21 Mn	958.07 Mn

Download Data